methyl 4-methoxy-3-phenoxybenzoate | 170124-07-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-methoxy-3-phenoxybenzoate
• 英文别名: 3-Phenoxy-4-methoxybenzoic acid methyl ester
• CAS: 170124-07-9
• 化学式: C₁₅H₁₄O₄
• 分子量: 258.274
• InChiKey: QEKMOFNOTYZQNU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  19
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 4-methoxy-3-phenoxybenzoate 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 sodium hydroxide 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 121.0h， 生成 (S)-3,5-dichloro-4-(2-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(4-methoxy-3-phenoxybenzoyloxy)-ethyl)pyridine 1-oxide
  参考文献：
  名称：

  Novel Class of Benzoic Acid Ester Derivatives as Potent PDE4 Inhibitors for Inhaled Administration in the Treatment of Respiratory Diseases

  摘要：

  The first steps in the selection process of a new anti-inflammatory drug for the inhaled treatment of asthma and chronic obstructive pulmonary disease are herein described. A series of novel ester derivatives of 1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3,5-di-chloropyriclin-4-yl) ethanol have been synthesized and evaluated for inhibitory activity toward cAMP-specific phosphodiesterase-4 (PDE4). In particular, esters of variously substituted benzoic acids were extensively explored, and structural modification of the alcoholic and benzoic moieties were performed to maximize the inhibitory potency. Several compounds with high activity in cell-free and cell-based assays were obtained. Through the evaluation of opportune in vitro ADME properties, a potential candidate suitable for inhaled administration in respiratory diseases was identified and tested in an in vivo model of pulmonary inflammation, proving its efficacy.

  DOI：

  10.1021/jm401549m
• 作为产物：
  描述：

  3-羟基-4-甲氧基苯甲酸甲酯 在 溶剂黄146 作用下， 以 四氢呋喃 、 乙醚 、 二氯甲烷 为溶剂， 反应 2.5h， 生成 methyl 4-methoxy-3-phenoxybenzoate
  参考文献：
  名称：

  邻-Quinol醋酸化学：反应朝芳基于亲核试剂与应用天然产物合成

  摘要：

  可以通过碘介导的乙酰氧基化苯酚脱芳香化反应轻松制备两种模型的邻苯二甲酸邻苯二酚乙酸酯，并评估其对各种基于芳基的亲核试剂（即芳基金属试剂和酚衍生物）的反应性。揭示了允许形成联芳基键的新型反应模式，并在此用于合成两种天然酚类。

  DOI：

  10.1021/acs.joc.7b00250

文献信息

• Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
  申请人：Warner-Lambert Company

  公开号：US06268387B1

  公开（公告）日：2001-07-31

  The present invention provides compounds of formula (I). The present invention also provides methods of treating or preventing inflammation or atherosclerosis, and a pharmaceutical composition that contains a compound of formula (I).

  本发明提供了化合物的结构式（I）。本发明还提供了治疗或预防炎症或动脉粥样硬化的方法，以及含有结构式（I）化合物的药物组合物。
• Aiding chronic written language expression difficulties: A case study
  作者：Linda Armstrong、Alison Macdonald

  DOI：10.1080/026870300401612

  日期：2000.1

  This paper describes some progress made in helping a young aphasic man (MD) to overcome what had appeared to be intractable written language expression difficulties, which continued to be significant for him. Traditional therapy methods based on cognitive neuropsychological assessment had failed to help MD to generalize improvement in his spelling particularly, but not exclusively, of longer and irregular words. Both a splint which allowed him to use his dominant hand for writing directly onto a computer screen and a simple word-processing programme with synthesized auditory feedback and lexical and grammatical prediction (Write:OutLoud(R) and Co:Writer(R)) enabled him to produce more normal written output (increased quantity and more normal quality). The discussion also focuses on how effectiveness of language therapy can be measured in this man with chronic aphasia.
• Synthesis of Functionalized Aryloxy 1,3-Butadienes and Their Transformation to Diaryl Ethers via Diels-Alder Cycloaddition Reactions
  作者：Richard K. Olsen、Xianqi Feng、Magnus Campbell、Rui-lian Shao、Shivanand K. Math

  DOI：10.1021/jo00124a010

  日期：1995.9

  The Diels-Alder reaction involving cycloaddition of aryloxy-substituted 1,3-butadienes with appropriate acetylenic electrophiles, followed by aromatization of the newly formed cyclohexadiene ring, has been used for the synthesis of diaryl ethers. The functionalized aryloxy 1,3-butadienes employed in this study were prepared by either of two methods: (1) methylenation of aryl esters via the Tebbe or related reagents, and (2) from 1-(aryloxy)-2-propanone by a sequence of formylation or alkylthio methlylenation, and subsequent enolsilylation. A tetrasubstituted butadiene containing two phenoxy groups at the 1 and 3 positions also was prepared by the latter method. The cycloaddition reactions of 2,3-dioxy-substituted dienes occurred in high yield, but, as expected, with no regioselectivity to furnish nearly equal mixtures of regioisomeric cycloadducts. In contrast, application of 1,2,3-trihetero-substituted dienes resulted in regiospecific cycloaddition reactions. Transformation of the cyclohexadiene cycloadducts to an aromatic ring was accomplished by dehydrogenation with DDQ or by elimination during the cycloaddition process of a molecule of an alkyl mercaptan. A chiral acetylenic ketone derived from D- or L-serine underwent condensation, without racemization, with aryloxy dienes to provide diaryl ethers related to the isodityrosine antibiotics.
• THIOUREA AND BENZAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING OR PREVENTING INFLAMMATORY DISEASES AND ATHEROSCLEROSIS
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP1042276A1

  公开（公告）日：2000-10-11
• US6268387B1
  申请人：——

  公开号：US6268387B1

  公开（公告）日：2001-07-31